Big Pharma's Legal Bill To Take Hit From Pay-For-Delay Ruling
The U.S. Supreme Court's ruling Monday requiring stepped-up scrutiny of so-called pay-for-delay deals will force the pharmaceutical industry to spend more money litigating patent suits and devising settlements that won't be...To view the full article, register now.
Already a subscriber? Click here to view full article